These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


451 related items for PubMed ID: 34214232

  • 1. Second-trimester contingent screening for small-for-gestational-age neonate.
    Nowacka U, Papastefanou I, Bouariu A, Syngelaki A, Akolekar R, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):177-184. PubMed ID: 34214232
    [Abstract] [Full Text] [Related]

  • 2. Competing-risks model for prediction of small-for-gestational-age neonate from biophysical and biochemical markers at 11-13 weeks' gestation.
    Papastefanou I, Wright D, Syngelaki A, Souretis K, Chrysanthopoulou E, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):52-61. PubMed ID: 33094535
    [Abstract] [Full Text] [Related]

  • 3. Competing-risks model for prediction of small-for-gestational-age neonate at 36 weeks' gestation.
    Papastefanou I, Thanopoulou V, Dimopoulou S, Syngelaki A, Akolekar R, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2022 Nov; 60(5):612-619. PubMed ID: 36056735
    [Abstract] [Full Text] [Related]

  • 4. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.
    Bakalis S, Peeva G, Gonzalez R, Poon LC, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):446-51. PubMed ID: 25826154
    [Abstract] [Full Text] [Related]

  • 5. Competing-risks model for prediction of small-for-gestational-age neonate from maternal characteristics, serum pregnancy-associated plasma protein-A and placental growth factor at 11-13 weeks' gestation.
    Papastefanou I, Wright D, Lolos M, Anampousi K, Mamalis M, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2021 Mar; 57(3):392-400. PubMed ID: 32936500
    [Abstract] [Full Text] [Related]

  • 6. Competing-risks model for prediction of small-for-gestational-age neonate from estimated fetal weight at 19-24 weeks' gestation.
    Papastefanou I, Nowacka U, Syngelaki A, Dragoi V, Karamanis G, Wright D, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2021 Jun; 57(6):917-924. PubMed ID: 33464642
    [Abstract] [Full Text] [Related]

  • 7. Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35-37 weeks' gestation.
    Ciobanu A, Rouvali A, Syngelaki A, Akolekar R, Nicolaides KH.
    Am J Obstet Gynecol; 2019 May; 220(5):486.e1-486.e11. PubMed ID: 30707967
    [Abstract] [Full Text] [Related]

  • 8. Two-stage approach for prediction of small-for-gestational-age neonate and adverse perinatal outcome by routine ultrasound examination at 35-37 weeks' gestation.
    Akolekar R, Panaitescu AM, Ciobanu A, Syngelaki A, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):484-491. PubMed ID: 31271475
    [Abstract] [Full Text] [Related]

  • 9. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A, Wright A, Syngelaki A, Maritsa VA, Da Silva AB, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
    [Abstract] [Full Text] [Related]

  • 10. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
    [Abstract] [Full Text] [Related]

  • 11. Routine ultrasound at 32 vs 36 weeks' gestation: prediction of small-for-gestational-age neonates.
    Ciobanu A, Khan N, Syngelaki A, Akolekar R, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):761-768. PubMed ID: 30883981
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Contingent screening for preterm pre-eclampsia.
    Wright D, Gallo DM, Gil Pugliese S, Casanova C, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2016 May; 47(5):554-9. PubMed ID: 26643929
    [Abstract] [Full Text] [Related]

  • 17. Stratification of pregnancy care based on risk of pre-eclampsia derived from biophysical and biochemical markers at 19-24 weeks' gestation.
    Litwinska M, Litwinska E, Astudillo A, Syngelaki A, Wright A, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2021 Sep; 58(3):360-368. PubMed ID: 33794058
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of competing-risks model with angiogenic factors in midgestation screening for preterm growth-related neonatal morbidity.
    Papastefanou I, Menenez M, Szczepkowska A, Gungil B, Syngelaki A, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2024 May; 63(5):613-618. PubMed ID: 38057964
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.